Komori
Business Partnership9212Green Earth Institute Co.,Ltd.Information and Communications, Services and Others

Addition of enzyme evaluation items under a joint research and development agreement for the commercialization of a biorefinery

Research and development items concerning the evaluation of enzymes suitable for the continuous simultaneous saccharification and fermentation process and the optimization of their operating conditions were added to the joint research and development agreement with Daio Paper Corporation. Total development costs to be incurred by GEI after the addition are expected to be ¥801.809 million over the 3-year period from fiscal 2025 through fiscal 2027.

Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
801809
¥ thousand
Wording
Conditional
How definitive the wording is.

Agreements reached under this partnership

Business Partnership
9212Green Earth Institute Co.,Ltd.
Alliance partnerDaio Paper Corporation
Details of the alliance
  1. 1

    We will evaluate domestic and overseas enzymes suitable for the Continuous Simultaneous Saccharification and Fermentation process and optimize their operating conditions.

These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.

Impact on Business Performance

This will increase net sales from the fiscal year ending September 2027 onward and will have no impact on results for the fiscal year ending September 2026.

Contract Date25 September 2026
Agreements reached under this partnership
ItemDetails
Name of alliance partnerDaio Paper Corporation
Type of allianceBusiness Partnership
Details of the allianceWe will evaluate domestic and overseas enzymes suitable for the Continuous Simultaneous Saccharification and Fermentation process and optimize their operating conditions.
Contract Date25 September 2026
Impact on Business PerformanceThis will increase net sales from the fiscal year ending September 2027 onward and will have no impact on results for the fiscal year ending September 2026.
Items this document does not state (18)
Alliance partner's business activitiesAlliance partner's locationAlliance partner's capitalAlliance partner's net salesAlliance partner's operating incomeNumber of shares acquiredAcquisition priceShareholding ratioOverview of the joint ventureOwnership ratioDispatch of directors and officersContract PeriodNumerical targets under the allianceShareholding PolicyDate of board resolutionAlliance start dateShare Acquisition Date and Payment DateChange in major shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To improve sugar yields and optimize the process through enzyme evaluation, further reduce manufacturing costs, and strengthen the competitiveness of the GWE process.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Addition of enzyme evaluation items under a joint research and development agreement for the commercialization of a biorefinery | Green Earth Institute Co.,Ltd. (9212) timely disclosure | Komori